Home Blog
Memory loss due to dementia. Senior man losing parts of head  as symbol of decreased mind function.
Cardiometabolic changes could take place a decade before the diagnosis of dementia, research suggests, providing a window of opportunity for its prevention.
T cells attacking cancer cells
The Chan Zuckerberg Initiative (CZI) has launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in AI model development in biology.
Blood Test Results In A Medical Lab
The research has the potential to change the way inflammatory diseases like heart disease, Alzheimer's disease, and certain cancers are diagnosed, and may also provide new insights for drug discovery.
HPAI H5N1 virus
A highly virulent strain of avian flu has been detected in dairy cows in Nevada. This development highlights the urgent need to be vigilant of emerging mutations and regular assessment of the threat of human-to-human transmission.
AI background, pill
A combination of “omics” data, lab studies, and machine learning can rapidly identify new treatment strategies for rare diseases, research shows.
Human gut microbiome picture showing a variety of microbes including fungi such as Candida albicans
A new study has uncovered a connection between the gut microbiome and anxiety, suggesting that microbial metabolites, particularly indoles, play a crucial role in regulating brain activity tied to anxious behavior.
LinusBio laser
By decoding complex metabolite patterns, the test can rule-out autism in children aged one to 36 months, a major drop from the current average of four years.
Cancer cells
A new discovery shows that a protein called RBM42 is a key player in influencing cells to ramp up production of MYC.
Human pancreas, gall bladder organ model, 3d rendering.
A targeted nasal approach to radiation delivery for pancreatic cancer is entering phase I and II clinical trials.
brain tumor
Researchers have uncovered a crucial mechanism driving sonic hedgehog driven medulloblastoma growth, identifying the Olig2 protein as a key trigger for awakening dormant cancer stem cells. Inhibiting Olig2 was demonstrated as a promising strategy to prevent tumor formation and relapse.

Related Content

Inside Precision Medicine